Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Women with PCOS are at higher risk for gum disease, and managing shared risk factors can help both conditions.

Stem cells can improve wound healing, reduce scars, promote hair growth, rejuvenate skin, and enhance fat grafts in plastic surgery, but there are still some concerns.

The FDA warned about safety issues with remdesivir and tofacitinib, finasteride is linked to suicidality, potent topical corticosteroids increase osteoporosis risk, henna can cause hemolysis in G6PD deficiency, chemotherapeutic agents can cause adverse reactions, drug interactions are common in cancer patients, ketamine can reduce at-risk drinking, high dose of anticholinergics increases dementia risk in Parkinson's patients, and prenatal exposure to second-generation antipsychotics increases pregnancy complications.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The 2018 ISPAN Meeting emphasized hands-on learning, patient safety, and professional growth in medical aesthetics and reconstructive practices.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

The document suggests that finasteride may cause depression and suicidal thoughts, while prostate surgery does not harm sexual health.

CEC levels may be a useful marker for predicting prostate cancer progression.

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Non-compliance with PCOS medication worsens symptoms and highlights the need for better patient support and education.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Melatonin helps regulate hair growth and protects the hair follicle from stress.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

The document concludes that various dermatological treatments and drugs can cause skin reactions and side effects.

Natural honey protects against Doxorubicin's harmful effects.

Cooling can protect hair follicles from chemotherapy damage by reducing drug uptake.

Milk thistle can protect skin from damage and aging.

Melatonin may protect hair follicle cells from damage caused by a chemotherapy drug.

Royal jelly can protect the heart from damage caused by paclitaxel.

A substance from Caulerpa racemosa seaweed may protect against skin damage caused by air pollution by reducing oxidative stress and cell death.

Low-intensity ultrasound may help protect hair follicles from chemotherapy-induced hair loss.

Topical calcitriol is safe for preventing hair loss during chemotherapy.

Scalp cooling may be less effective for women of color on certain chemotherapy treatments.

The new drug delivery system improves exemestane's absorption and effectiveness.

Preventing and managing skin issues from cancer treatment is crucial, especially in high UV areas like Australia and New Zealand.

Kombucha tea extract may protect skin from damage in hot and humid conditions.

Keratinocyte Growth Factor-Hair Serum may help prevent hair loss during chemotherapy, but more research is needed.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.